Emami Limited Sets Board Meeting for Q2 Results and Interim Dividend Consideration

1 min read     Updated on 10 Oct 2025, 06:57 PM
scanx
Reviewed by
Shriram ShekharScanX News Team
whatsapptwittershare
Overview

Emami Limited has announced a board meeting for November 10, 2025, to review Q2 financial results for FY 2025-26 and consider an interim dividend. The meeting will cover unaudited standalone and consolidated results for the quarter ended September 30, 2025. A trading window closure is in effect from October 1 to November 12, 2025, to prevent insider trading. The company has informed the National Stock Exchange and BSE Limited about the meeting, complying with SEBI regulations.

21648481

*this image is generated using AI for illustrative purposes only.

Emami Limited , a prominent player in the Indian FMCG sector, has announced a crucial board meeting scheduled for November 10, 2025. The meeting agenda includes the review of the company's financial performance for the second quarter of the fiscal year 2025-26 and the potential declaration of an interim dividend.

Key Meeting Details

Aspect Details
Date November 10, 2025
Primary Agenda 1. Review Q2 Financial Results
2. Consider Interim Dividend
Financial Period Quarter ended September 30, 2025
Results Type Unaudited Standalone and Consolidated

Trading Window Closure

In compliance with regulatory requirements, Emami Limited has implemented a trading window closure for share dealings:

Event Date
Closure Start October 1, 2025
Closure End November 12, 2025

This temporary restriction on share trading is a standard practice to prevent insider trading and ensure fair market practices during sensitive periods, such as before the announcement of financial results.

Regulatory Compliance

The company has duly informed the National Stock Exchange of India Ltd. and BSE Limited about the scheduled board meeting, adhering to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This transparency ensures that all stakeholders are informed about potential market-moving events.

Investor Implications

The upcoming board meeting is significant for Emami Limited's shareholders and potential investors for several reasons:

  1. Financial Performance Insights: The Q2 results will provide crucial insights into the company's performance amidst current market conditions.
  2. Dividend Prospects: The consideration of an interim dividend could signal the company's financial health and commitment to shareholder returns.
  3. Market Reaction: The announcements from this meeting may influence the company's stock price in the short term.

Investors and market analysts will be keenly watching the outcomes of this board meeting, as it may provide indicators of Emami Limited's financial stability and growth trajectory in the current fiscal year.

As the meeting date approaches, stakeholders are advised to stay tuned for the official announcement of the Q2 results and any decision regarding the interim dividend. These outcomes will be critical in assessing Emami Limited's financial position and its implications for the broader FMCG sector in India.

Historical Stock Returns for Emami

1 Day5 Days1 Month6 Months1 Year5 Years
-1.02%-3.78%-10.48%-11.22%-25.91%+54.07%

Emami Charts Global Expansion Course, Eyes New Markets for Growth

1 min read     Updated on 29 Aug 2025, 07:43 PM
scanx
Reviewed by
Ashish ThakurScanX News Team
whatsapptwittershare
Overview

Emami Ltd announces plans to enter new overseas markets, building on its 11% CAGR in international business over the past five years. The company has expanded manufacturing facilities in Bangladesh, the Middle East, and Africa to support growth. Emami reported revenue of Rs 3,809 crore and aims to drive growth through health and wellness segments. The company's AGM approved key leadership re-appointments and the appointment of new Secretarial Auditors.

18022411

*this image is generated using AI for illustrative purposes only.

Emami Ltd , a prominent player in India's Fast-Moving Consumer Goods (FMCG) sector, has unveiled ambitious plans to accelerate its international growth by entering new overseas markets. The announcement comes as part of the company's strategy to capitalize on its strong performance and expand its global footprint.

International Growth Trajectory

R S Goenka, Chairman of Emami, reported that the company's international business has achieved an impressive 11.00% compound annual growth rate (CAGR) over the past five years. This robust performance underscores Emami's successful expansion beyond Indian borders and its growing appeal in global markets.

Manufacturing Expansion

To support its international growth ambitions, Emami has strategically expanded its manufacturing operations in key regions. The company has established production facilities in Bangladesh, the Middle East, and Africa, positioning itself to meet local demand more efficiently and respond swiftly to market dynamics in these regions.

Domestic Performance

While focusing on international expansion, Emami continues to maintain a strong presence in its home market. The company recorded a revenue of Rs 3,809.00 crore, demonstrating its solid financial foundation.

Future Outlook

Goenka expressed optimism about the operating environment, citing several favorable factors:

  • Tapering inflation
  • Moderating interest rates
  • Resilient rural sentiment

These conditions are expected to create a more conducive environment for business growth and consumer spending.

Strategic Focus on Health and Wellness

Emami is setting its sights on driving strong revenue growth through its health and wellness segments. This strategic focus aligns with growing global trends towards personal health and well-being, potentially opening up new avenues for product development and market penetration.

Corporate Governance and Leadership

During Emami's 42nd Annual General Meeting (AGM), several key corporate decisions were approved:

  • Re-appointment of Shri Mohan Goenka as Vice-Chairman & Whole-time Director for a five-year term.
  • Re-appointment of Shri Sushil Kumar Goenka as Whole-time Director for a five-year term.
  • Appointment of M/s. MKB & Associates as the company's Secretarial Auditors for a five-year term.

These appointments reflect Emami's commitment to maintaining strong leadership and corporate governance as it pursues its global expansion strategy.

Conclusion

As Emami sets its sights on new international horizons, the company appears well-positioned to leverage its strong domestic foundation and recent manufacturing expansions. With a focus on health and wellness segments and an optimistic outlook on economic conditions, Emami is charting a course for sustained growth in both domestic and international markets.

Historical Stock Returns for Emami

1 Day5 Days1 Month6 Months1 Year5 Years
-1.02%-3.78%-10.48%-11.22%-25.91%+54.07%
More News on Emami
Explore Other Articles
536.85
-5.55
(-1.02%)